FDA Approves Kalydeco (VX-770) — First Drug That Targets the Underlying Cause of Cystic Fibrosis
Originally posted in Cystic Fibrosis Foundation
No Comments »
RSS feed for comments on this post. TrackBack URL
|
Jan
31 2012 |
©Uncle & Drunken Crayfish Productions 2011
www.DrunkenCrayfish.com
Visit our NEW site at
PocketBiker.com